Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about draft letter to be dispatched to members whose email addresses not registered with the company/ depository participants
BIOFILCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biofil Chemicals & Pharmaceuticals has informed BSE and NSE about a draft letter being sent to shareholders whose email addresses are not registered with the company, its Registrar & Transfer Agent, or Depository Participants. The letter informs these shareholders that the 40th Annual General Meeting (AGM) is scheduled for Saturday, September 27, 2025 at 3:00 PM, to be held via Video Conferencing (VC)/OAVM. The Annual Report for FY 2024-25 and AGM notice are available on the company's website and can also be accessed on the BSE and NSE websites. Shareholders wishing to receive a physical copy of the Annual Report or update their contact/bank/nomination details are directed to contact the Registrar, Ankit Consultancy Private Limited, or write to the company's compliance email.
This is a routine regulatory compliance communication with no material impact on the stock price or shareholders. It simply ensures that shareholders without registered emails are informed about the AGM and can access the Annual Report through alternative means.